Finnhub•2026-04-20
Invivyd Announces Chairman Marc Elia to Speak at POLITICO Health Care SummitIVVD — Invivyd Inc
NASDAQ · Biotechnology · Biotechnology
$1.59-31.47%Market cap361.72M
- Latest Close
- $1.59
- 30-Day Move
- -31.5%
- Market Cap
- $362M
- Shares Outstanding
- 282,590,000
- P/B Ratio
- 2.83
- ROE
- -21.7%
NASDAQ:IVVDBiotechnology / BiotechnologyDelayed public snapshot
Invivyd Inc
A read-only Alphactor snapshot forInvivyd Inc. It uses the same research structure as the app, but with delayed data and shallow depth so search visitors can evaluate the stock before signing up.
Snapshot as of2026-04-21
Topline snapshot
Latest Close
$1.59
30-Day Move
-31.5%
Market Cap
$362M
Shares Outstanding
282,590,000
P/B Ratio
2.83
ROE
-21.7%
Not investment advice. Signals and scores shown here are model outputs derived from historical data, not recommendations. Past performance does not guarantee future results. Do your own research before trading. Full disclaimer
Chart snapshot
$1.59
-31.5%last 90 delayed daily bars
Market cap$362M
90D High
$3.01
90D Low
$1.17
Avg Volume
3,431,909
What stands out
Gross margin is running at 93.0%, which gives a quick read on operating quality before you open the full model.
Net margin is -98.3%, useful for comparing IVVD against peers in Biotechnology.
IVVD is down 31.5% over the last 30 trading days shown on this page.
Latest operating income is $-13M, which helps anchor the headline ratios with an actual earnings figure.
Research snapshot
Composite Fair Value
$1.74
Rule of 40
1.4%
Dark Pool Short %
41.2%
Fundamentals snapshot
Latest Close
$1.59
30-Day Move
-31.5%
Market Cap
$362M
Shares Outstanding
282,590,000
P/B Ratio
2.83
ROE
-21.7%
ROA
-19.0%
Gross Margin
93.0%
Operating Margin
-104.0%
Net Margin
-98.3%
Debt / Equity
0
Current Ratio
7.24
Latest Revenue
$17M
Financial statement snapshot
Revenue
$17M
Gross Profit
$16M
Operating Income
$-13M
Net Income
$-11M
Gross Margin
9299.0%
Net Margin
-9825.0%
Current Ratio
7.24
Debt / Equity
0.00
Valuation snapshot
Fair Value
$1.74
Upside / Downside
+9.4%
Signal
Fairly Valued
Implied Growth
--
EV/Rev
$1.74
Growth Assumption
5.0%
Discount Rate
10.5%
Terminal Growth
2.0%
Base FCF
--
Valuation spread
Current Price
$1.59
Composite Fair Value
$1.74
EV/Rev
$1.74
After signup
The full valuation workspace goes deeper
Adjust DCF growth, discount, and terminal assumptions instead of relying on one static snapshot.
Open the deeper balance-sheet and cash-flow views to inspect debt, liquidity, and cash generation line by line.
Compare multiple valuation models against peers and save your own thesis instead of re-reading a fixed public state.
Negative FCF — company is cash-flow negative. Reverse DCF requires positive cash flows.
Quality snapshot
Altman Z
1.77
Distress
Piotroski
3
Weak (0-3)
Cash Conversion
1.11x
Rule of 40
1.4%
Concerning
Annual financial history
Annual performance mix
| Period | Revenue | Operating Income | Net Income | Free Cash Flow |
|---|---|---|---|---|
| 2022-12-31 | $0 | $-226M | $-241M | $-222M |
| 2023-12-31 | $0 | $-208M | $-199M | $-174M |
| 2024-12-31 | $25M | $-177M | $-170M | $-171M |
| 2025-12-31 | $53M | $-56M | $-52M | $-58M |
After signup
The app opens the full statement deep dive
Extend the history well beyond this public snapshot to inspect longer cycles and regime changes.
Move from summary lines into detailed balance-sheet and cash-flow rows for working capital, debt, and capex analysis.
Cross-link statement changes with alerts, watchlists, and saved research workflows after signup.
News snapshot
After signup
The full sentiment workspace adds context
Go past the public headlines into fuller article history, source cross-checks, and deeper narrative tracking.
Tie news into alerts, watchlists, and conviction changes instead of browsing one static batch of stories.
Insider activity snapshot
Buy Value
$125,000
Sell Value
$520,905.78
Buys
1
Sells
20
Buy Value
$125,000
Sell Value
$520,905.78
Buy/Sell Ratio
0.05x
After signup
The full app goes deeper on insider behavior
Inspect longer insider history, recurring buyers and sellers, and the broader transaction context beyond this snapshot.
Continue into deeper institutional and alternative-data views once you sign up.
Recent insider transactions
| Date | Name | Type | Shares | Price |
|---|---|---|---|---|
| 2026-02-18 | Allen Robert D. III | Sell | 19,392 | $1.58 |
| 2026-02-18 | Green Julie | Sell | 20,964 | $1.58 |
| 2026-02-18 | Lee Timothy Edward | Sell | 20,964 | $1.58 |
| 2026-02-18 | Andersen Jill | Sell | 34,939 | $1.58 |
| 2026-02-18 | Duke William E. | Sell | 20,964 | $1.58 |
| 2026-02-17 | Allen Robert D. III | Sell | 18,189 | $1.54 |
| 2026-02-17 | Green Julie | Sell | 19,663 | $1.54 |
| 2026-02-17 | Lee Timothy Edward | Sell | 19,663 | $1.54 |
ETF holders snapshot
| ETF | Shares | Weight | As Of |
|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 7,392,820 | 0.03% | 2025-12-31 |
| MUTUAL FUND SERIES TRUST-Eventide Healthcare & Life Sciences Fund | 5,809,256 | 0.02% | 2025-12-31 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 4,736,624 | 0.02% | 2026-02-28 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1,900,134 | 0.01% | 2025-12-31 |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 921,688 | 0.00% | 2026-02-28 |
| Driehaus Mutual Funds-Driehaus Micro Cap Growth Fund | 844,335 | 0.00% | 2025-12-31 |
| iShares Trust-iShares Core S&P Total U.S. Stock Market ETF | 732,571 | 0.00% | 2026-02-28 |
| FINANCIAL INVESTORS TRUST-Emerald Growth Fund | 428,847 | 0.00% | 2026-01-31 |
After signup
The deeper ownership view shows who is leaning in
Open richer institutional and holder diffs to see position changes across filings instead of one static snapshot.
Use those ownership shifts alongside conviction and alerts in the full app workflow.
Institutional holders snapshot
Charles Schwab
Filed 2025-08-12
--
--
Qube Research & Technologies
Filed 2025-05-15
--
--
Two Sigma Advisers
Filed 2025-05-15
--
--
Vanguard Group
Filed 2026-01-29
$26M
+85.7%
Goldman Sachs
Filed 2026-02-10
$5M
+4964.4%
Geode Capital Management
Filed 2026-02-09
$5M
+180.8%
BlackRock
Filed 2024-08-13
$5M
--
Renaissance Technologies
Filed 2026-02-12
$3M
--
Dark-pool activity snapshot
For informational and educational purposes only. Not financial advice. Learn more
Related reading
Research and strategy guides from the alphactor blog.
Accruals Quality: How to Spot Earnings That Aren't Real
Accruals measure the gap between reported earnings and actual cash. Widening accruals is one of the most reliable red flags in financial analysis — Sloan's…
Altman Z-Score: A Bankruptcy Predictor That Still Works
Edward Altman's 1968 discriminant model predicts bankruptcy within two years about 72% of the time at its distress threshold.
Balance Sheet Deep Dive
Balance sheet changes lead income statements by 2-6 quarters. Net debt, receivables days, and goodwill are the lines that move stocks first.